Unlocking Novel Chemistry
Designing Better Therapeutics
Ansaris was established in February 2009 to focus on small molecule drug discovery challenges, by leveraging 10 years of drug discovery expertise.
Ansaris was established in February 2009 to focus on small molecule drug discovery challenges, by leveraging 10 years of drug discovery expertise:
- Fragment-based drug design technology from Sarnoff Corporation
- Protein modeling technology from Protein Mechanics, Inc
- Evolution of technologies into next generation and advancement of drug candidates into development from Locus Pharmaceuticals
